Stanford neuroscientist Andrew Huberman says the real AI arms race is about controlling your brain
Stanford neuroscientist Andrew Huberman predicts that major AI companies like OpenAI and Meta will transition into biotech firms. He suggests the future of AI lies in non-invasive brain-computer interfaces that can monitor and alter cognitive states like focus and motivation.
Why it matters
This highlights a potential shift in the AI industry toward neurotechnology, raising significant ethical and privacy concerns regarding the direct manipulation of human brain activity.
Andrew Huberman says AI's next big race will be to control your brain. Jeff Spicer/Getty Images for smoov Behind AI's race for better models is a race to read and alter brain activity, Andrew Huberman says. The Stanford neuroscientist says he expects OpenAI, Meta, and Anthropic to become biotech firms. "That's what the real arms race of AI is about," Huberman said. The AI arms race is a sprint to build the best model — or so you thought. Andrew Huberman, the Stanford neuroscientist and podcaster, said that tech companies, including OpenAI, Meta, and Anthropic, will ultimately become biotech companies, pursuing ways to read and alter brain activity without implants. "The goal is to be able to read and write from your brain non-invasively," he said in an episode of "Invest Like The Best" released on Tuesday.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in